SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001193125-19-074931
Filing Date
2019-03-14
Accepted
2019-03-14 17:00:33
Documents
2
Group Members
BIOGEN SWITZERLAND HOLDINGS GMBH

Document Format Files

Seq Description Document Type Size
1 SC 13D d700791dsc13d.htm SC 13D 91115
2 EX-1.01 d700791dex101.htm EX-1.01 4227
  Complete submission text file 0001193125-19-074931.txt   97390
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filed by) CIK: 0000875045 (see all company filings)

IRS No.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453
Business Address C/O NIGHTSTAR, INC. 203 CRESCENT STREET, SUITE 303 WALTHAM MA 02453 781-778-7553
Nightstar Therapeutics plc (Subject) CIK: 0001711675 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-90131 | Film No.: 19681772
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1